newsfilter
← Latest News
GlobeNewswire·

Lucy Scientific to Acquire SANA-013 Psychedelic Assets from Drug Developer Wesana Health

Transaction subject to Wesana shareholder approval and expected to close in Q2 2023SANA-013 combination of psilocybin and CBD being developed for potential treatment of mental health/CNS conditions expected to commence